High dose versus moderate dose methadone maintenance: Is there a better outcome?

Journal of Addictive Diseases

Volumn 28, Issue 4, 2009, Pages 399-405

  Fareed, Ayman ^a,b   Casarella, Jennifer ^a   Roberts, Mary ^b   Sleboda, Mary ^b   Amar, Richard ^a   Vayalapalli, Shreedevi ^a   Drexler, Karen ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

High dose; Methadone; Moderate dose; Outcome

Indexed keywords

COCAINE; METHADONE; OPIATE;

ADULT; ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHADONE TREATMENT; OPIATE ADDICTION; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; COCAINE-RELATED DISORDERS; FEMALE; GEORGIA; HUMANS; MALE; MEDICAL RECORDS; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 75149191344     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550880903183042     Document Type: Article

References (30)

1. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 1965; 193:80-84
2. Dole VP, Nyswander ME. Rehabilitation of heroin addicts after blockade with methadone. N Y State J Med 1966; 66:2011-2017
3. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 343:1290-1297
4. Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1998; 88:34-39
5. Preston KL, Umbricht A, Epstein DH. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch Gen Psychiatry 2000; 57:395-404.
6. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999; 281:1000-1005
7. Ling W, Wesson DR, Charuvastra C, Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996; 53:401-407
8. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 1997; 54:713-720
9. Caplehorn JRM, Bell J. Methadone dosage and retention of patients in maintenance treatment. Med J Aust 1991; 154:195-199
10. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003; 3:CD002208.
11. Pollack HA, D'Aunno T. Dosage patterns in methadone treatment: results from a national survey, 1988-2005. Health Serv Res 2008 Dec.; 43(6):2143-2163
12. Maxwell S, Shinderman M. Optimizing response to methadone maintenance treatment: use of higher dose methadone. J Psychoactive Drugs 1999; 31:95-102.
13. Maxwell S, Shinderman MS. Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dosemethadone. J Addict Dis 2002; 21:1-12.
14. Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML. High-dosemethadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl) 2002; 161:202-212
15. Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin selfadministration in opioid-dependent volunteers. Addiction 2005; 100:1496-1509
16. McLellan AT, Luborsky L,Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: TheAddiction Severity Index. J Nerv Ment Dis 1980; 168:26-33.
17. Meresaar U, Nilsson MI, Holmstrand J, Anggard E. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Eur J Clin Pharmacol 1981; 20:473-478
18. Wolff K, Hay AW, Raistrick D, Calvert R. Steadystate pharmacokinetics of methadone in opioid addicts. Eur J Clin Pharmacol 1993; 44:189-194
19. Kristensen K, Blemmer T, Angelo HR, Christrup LL, Drenck,NE, Rasmussen SN, Sjøgren P. Stereoselective pharmacokinetics of methadone in chronic pain patients. Ther Drug Monit 1996; 18:221-227
20. Inturrisi CE, Verebely K. The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther 1972; 13:633-7.
21. Inturrisi CE, Verebely K. Disposition of methadone in man after a single oral dose. Clin Pharmacol Ther 1972; 13:923-930
22. Bellward GD, Warren PM, Howald W, Axelson JE, Abbott FS. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses. Clin Pharmacol Ther 1977; 22:92-99
23. Nilsson M-I, Anggard E, Holmstrand J, Gunne LM. Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase. Eur J Clin Pharmacol 1982; 22:343-349
24. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986; 25:297-312.
25. Oda Y, Kharasch ED. Metabolism ofmethadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presysternic clearance and bioactivation. J Pharmacol Exp Ther 2001; 298:1021-1032
26. Li Y. Interindividual variability of methadone response: impact of genetic polymorphisms. Mol Diagn Ther 2008; 12:109-124.
27. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. New York: Springer-Verlag, 1991.
28. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988 Sep; 29(3):214-226
29. Zanis DA,Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998; 52:257-260
30. Woody GE, Kane V, Lewis K, Thompson R. Premature deaths after discharge from methadone maintenance: a replication. J Addict Med 2007; 1:180-185